Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN)

1.82 -0.03 (1.62%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/22 *Est.)

Latest Headlines

Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Zulueta Alfonso G June 29, 2022 8:09 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: ENRIGHT ERIN S. June 29, 2022 8:08 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: VAN HEEK G JAN June 29, 2022 8:08 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Peterson Kristine June 29, 2022 8:07 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: O'Sullivan Patrick J June 29, 2022 8:06 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Ekman Lars June 29, 2022 8:05 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: WOLD OLSEN PER June 29, 2022 8:04 PM - SEC Filing Greater Competition Does Not Impact Investment Thesis - Cantor Fitzgerald Reiterates Amarin Corporation (AMRN)at Overweight June 22, 2022 5:44 PM - StreetInsider Form DEFA14A AMARIN CORP PLC\UK June 17, 2022 4:52 PM - SEC Filing Form SC 13D/A AMARIN CORP PLC\UK Filed by: Sarissa Capital Management LP June 16, 2022 6:05 AM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Jun 13 Filed by: WOLD OLSEN PER June 15, 2022 8:02 PM - SEC Filing Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting June 15, 2022 4:50 PM - BizWire Amarin Corp. (AMRN) Announces Positive Recommendation from UK's NICE for Reimbursement of VAZKEPA June 10, 2022 6:00 AM - StreetInsider Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl) June 10, 2022 6:00 AM - Globe NewsWire Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl) June 10, 2022 6:00 AM - StreetInsider Form 8-K AMARIN CORP PLC\UK For: Jun 01 June 6, 2022 4:36 PM - SEC Filing JPMorgan on Underweight-rated Amarin Corporation (AMRN), 'we see a difficult path ahead for the stock' June 6, 2022 12:12 PM - StreetInsider Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug June 6, 2022 9:34 AM - StreetInsider Amarin Corp. (AMRN) Announces Comprehensive Cost Reduction Plan June 6, 2022 8:33 AM - StreetInsider Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business June 6, 2022 8:30 AM - Globe NewsWire Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business June 6, 2022 8:30 AM - StreetInsider Amarin Corp. (AMRN) Appoints Tom Reilly as New Chief Financial Officer June 6, 2022 8:16 AM - StreetInsider Amarin Appoints Tom Reilly as New Chief Financial Officer June 6, 2022 8:15 AM - Globe NewsWire Amarin Appoints Tom Reilly as New Chief Financial Officer June 6, 2022 8:15 AM - StreetInsider Sarissa Capital held talks with Amarin Corp. (AMRN) on ways to maximize value June 3, 2022 9:29 AM - StreetInsider Form SC 13D/A AMARIN CORP PLC\UK Filed by: Sarissa Capital Management LP June 3, 2022 9:18 AM - SEC Filing Form DEF 14A AMARIN CORP PLC\UK For: Jun 27 May 24, 2022 5:17 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: May 16 Filed by: Zulueta Alfonso G May 20, 2022 8:25 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: May 16 Filed by: ENRIGHT ERIN S. May 20, 2022 8:25 PM - SEC Filing Form 3 AMARIN CORP PLC\UK For: May 16 Filed by: Zulueta Alfonso G May 20, 2022 8:23 PM - SEC Filing Form 3 AMARIN CORP PLC\UK For: May 16 Filed by: ENRIGHT ERIN S. May 20, 2022 8:23 PM - SEC Filing Form 8-K AMARIN CORP PLC\UK For: May 16 May 20, 2022 7:48 AM - SEC Filing Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes May 19, 2022 8:24 AM - StreetInsider Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes May 19, 2022 8:24 AM - StreetInsider Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes May 19, 2022 8:24 AM - StreetInsider Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes May 19, 2022 8:24 AM - StreetInsider Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes May 19, 2022 8:24 AM - StreetInsider Amarin Announces Appointment of New Directors and Board Leadership Changes May 19, 2022 8:24 AM - StreetInsider Amarin Announces Appointment of New Directors and Board Leadership Changes May 19, 2022 8:23 AM - Globe NewsWire Amarin Corp. (AMRN) Reports Research Supporting Potential for VASCEPA to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs May 16, 2022 8:04 AM - StreetInsider Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Car May 16, 2022 8:00 AM - Globe NewsWire Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Car May 16, 2022 8:00 AM - StreetInsider Amarin to Present at Two Upcoming Investor Conferences May 12, 2022 8:01 AM - StreetInsider Amarin to Present at Two Upcoming Investor Conferences May 12, 2022 8:00 AM - Globe NewsWire UPDATE: JPMorgan Downgrades Amarin Corporation (AMRN) to Underweight May 6, 2022 3:34 AM - StreetInsider H.C. Wainwright Downgrades Amarin Corporation (AMRN) to Neutral May 5, 2022 6:14 AM - StreetInsider SVB Leerink Downgrades Amarin Corporation (AMRN) to Market Perform May 5, 2022 6:09 AM - StreetInsider Northland Capital Markets Downgrades Amarin Corporation (AMRN) to Market Perform May 4, 2022 3:27 PM - StreetInsider Amarin Corporation (AMRN) PT Lowered to $9 at Cowen May 4, 2022 12:55 PM - StreetInsider Form 8-K AMARIN CORP PLC\UK For: May 04 May 4, 2022 7:10 AM - SEC Filing Form 10-Q AMARIN CORP PLC\UK For: Mar 31 May 4, 2022 7:06 AM - SEC Filing Amarin Corp. (AMRN) Misses Q1 EPS by 6c May 4, 2022 7:04 AM - StreetInsider Amarin Reports First Quarter 2022 Financial Results and Provides Business Update May 4, 2022 7:00 AM - Globe NewsWire Form 4 AMARIN CORP PLC\UK For: May 02 Filed by: Marks Jason M. May 3, 2022 8:04 PM - SEC Filing Amarin Corp. (AMRN) Reports New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction May 3, 2022 8:12 AM - StreetInsider New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack) May 3, 2022 8:00 AM - Globe NewsWire New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack) May 3, 2022 8:00 AM - StreetInsider Form 10-K/A AMARIN CORP PLC\UK For: Dec 31 May 2, 2022 4:03 PM - SEC Filing Amarin Corp. (AMRN) Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance for VASCEPA April 26, 2022 8:50 AM - StreetInsider Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl) April 26, 2022 8:50 AM - StreetInsider Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl) April 26, 2022 8:49 AM - Globe NewsWire Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022 April 19, 2022 7:30 AM - Globe NewsWire Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022 April 19, 2022 7:30 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Apr 12 Filed by: Mikhail Karim April 14, 2022 8:03 PM - SEC Filing Amarin Corp. (AMRN) Announces Eicosapentaenoic Acid Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes April 1, 2022 7:03 AM - StreetInsider Eicosapentaenoic Acid (EPA) Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes April 1, 2022 7:00 AM - Globe NewsWire Eicosapentaenoic Acid (EPA) Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes April 1, 2022 7:00 AM - StreetInsider Full Article List